DAWN – Day One Biopharmaceuticals, Inc.
DAWN
$7.20Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $737,510,400.00
EPSttm : -0.89
Day One Biopharmaceuticals, Inc
$7.20
Float Short %
13.27
Margin Of Safety %
Put/Call OI Ratio
0.17
EPS Next Q Diff
-0.02
EPS Last/This Y
-0.17
EPS This/Next Y
0.36
Price
7.2
Target Price
23.56
Analyst Recom
1.2
Performance Q
14.83
Relative Volume
1.06
Beta
-1.27
Ticker: DAWN
21 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-07-25 | DAWN | 7.24 | 0.06 | 0.00 | 3098 |
2025-07-28 | DAWN | 7.11 | 0.06 | 0.03 | 3123 |
2025-07-29 | DAWN | 6.98 | 0.06 | 0.00 | 3219 |
2025-07-30 | DAWN | 6.86 | 0.06 | 0.00 | 3180 |
2025-07-31 | DAWN | 6.7 | 0.07 | 0.00 | 3143 |
2025-08-01 | DAWN | 6.64 | 0.06 | 0.10 | 3176 |
2025-08-04 | DAWN | 6.74 | 0.07 | 0.00 | 3136 |
2025-08-05 | DAWN | 6.87 | 0.07 | 0.06 | 3128 |
2025-08-06 | DAWN | 5.82 | 0.07 | 2.02 | 3373 |
2025-08-07 | DAWN | 6.03 | 0.11 | 0.12 | 3521 |
2025-08-08 | DAWN | 6.14 | 0.11 | 0.00 | 3580 |
2025-08-11 | DAWN | 5.9 | 0.11 | 0.00 | 3675 |
2025-08-12 | DAWN | 6.14 | 0.11 | 0.00 | 3685 |
2025-08-13 | DAWN | 6.22 | 0.11 | 0.00 | 3709 |
2025-08-14 | DAWN | 6.26 | 0.11 | 1.25 | 3707 |
2025-08-15 | DAWN | 6.76 | 0.11 | 0.00 | 3716 |
2025-08-18 | DAWN | 6.8 | 0.19 | 0.00 | 2149 |
2025-08-19 | DAWN | 6.82 | 0.18 | 0.23 | 2299 |
2025-08-20 | DAWN | 6.82 | 0.17 | 0.00 | 2355 |
2025-08-21 | DAWN | 6.99 | 0.17 | 0.00 | 2298 |
2025-08-22 | DAWN | 7.2 | 0.17 | 0.10 | 2294 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-07-25 | DAWN | 7.23 | -591.0 | - | -1.35 |
2025-07-28 | DAWN | 7.19 | -586.1 | - | -1.35 |
2025-07-29 | DAWN | 6.99 | -586.1 | - | -1.35 |
2025-07-30 | DAWN | 6.87 | -586.1 | - | -1.35 |
2025-07-31 | DAWN | 6.71 | -586.1 | - | -1.35 |
2025-08-01 | DAWN | 6.65 | -586.1 | - | -1.35 |
2025-08-04 | DAWN | 6.74 | -586.1 | - | -1.35 |
2025-08-05 | DAWN | 6.88 | -586.1 | - | -1.35 |
2025-08-06 | DAWN | 5.82 | -586.1 | - | -1.35 |
2025-08-07 | DAWN | 6.03 | -586.1 | - | -1.35 |
2025-08-08 | DAWN | 6.10 | -586.1 | - | -1.18 |
2025-08-11 | DAWN | 5.90 | -180.0 | - | -1.27 |
2025-08-12 | DAWN | 6.14 | -179.8 | - | -1.27 |
2025-08-13 | DAWN | 6.21 | -179.8 | - | -1.27 |
2025-08-14 | DAWN | 6.26 | -179.8 | - | -1.27 |
2025-08-15 | DAWN | 6.76 | -179.8 | - | -1.19 |
2025-08-18 | DAWN | 6.80 | -173.3 | - | -1.19 |
2025-08-19 | DAWN | 6.82 | -173.3 | - | -1.19 |
2025-08-20 | DAWN | 6.81 | -173.3 | - | -1.19 |
2025-08-21 | DAWN | 6.99 | -173.3 | - | -1.19 |
2025-08-22 | DAWN | 7.20 | -173.3 | - | -1.19 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-07-25 | DAWN | -0.18 | 0.38 | 13.77 |
2025-07-28 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-29 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-30 | DAWN | -0.18 | -1.37 | 13.77 |
2025-07-31 | DAWN | -0.18 | -1.37 | 13.77 |
2025-08-01 | DAWN | -0.18 | -1.37 | 13.77 |
2025-08-04 | DAWN | -0.18 | -2.93 | 13.77 |
2025-08-05 | DAWN | -0.18 | -2.93 | 13.77 |
2025-08-06 | DAWN | -0.18 | -2.93 | 13.77 |
2025-08-07 | DAWN | -0.18 | -2.93 | 13.77 |
2025-08-08 | DAWN | -0.18 | -2.93 | 13.62 |
2025-08-11 | DAWN | -0.18 | -3.02 | 13.62 |
2025-08-12 | DAWN | -0.18 | -3.02 | 13.13 |
2025-08-13 | DAWN | -0.18 | -3.02 | 13.13 |
2025-08-14 | DAWN | -0.18 | -3.02 | 13.13 |
2025-08-15 | DAWN | -0.18 | -3.02 | 13.13 |
2025-08-18 | DAWN | -0.18 | -7.01 | 13.27 |
2025-08-19 | DAWN | -0.17 | -7.01 | 13.27 |
2025-08-20 | DAWN | -0.27 | -7.01 | 13.27 |
2025-08-21 | DAWN | -0.27 | -7.01 | 13.27 |
2025-08-22 | DAWN | -0.20 | -7.01 | 13.27 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.29
Avg. EPS Est. Current Quarter
-0.28
Avg. EPS Est. Next Quarter
-0.31
Insider Transactions
-0.2
Institutional Transactions
-7.01
Beta
-1.27
Average Sales Estimate Current Quarter
38
Average Sales Estimate Next Quarter
41
Fair Value
Quality Score
42
Growth Score
29
Sentiment Score
88
Actual DrawDown %
74.9
Max Drawdown 5-Year %
Target Price
23.56
P/E
Forward P/E
PEG
P/S
3.93
P/B
1.6
P/Free Cash Flow
EPS
-0.91
Average EPS Est. Cur. Y
-1.19
EPS Next Y. (Est.)
-0.83
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-50.63
Relative Volume
1.06
Return on Equity vs Sector %
-45.3
Return on Equity vs Industry %
-32.4
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.17
EBIT Estimation
Sector: Healthcare
Industry: Biotechnology
Employees: 182
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading